Machine Learning to Predict Anti –Tumor Necrosis Factor Drug Responses of Rheumatoid Arthritis Patients by Integrating Clinical and Genetic Markers

ConclusionThe model described here shows promise in guiding treatment decisions in clinical practice, based primarily on clinical profiles with additional genetic information.

Source: Arthritis and Rheumatology - November 3, 2019 Category: Rheumatology Authors: Yuanfang Guan, Hongjiu Zhang, Daniel Quang, Ziyan Wang, Stephen C. J. Parker, Dimitrios A. Pappas, Joel M. Kremer, Fan Zhu Tags: Original Article Source Type: research